Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial

BACKGROUND: Liquid biopsy based on cell-free DNA circulating in plasma has shown solid results as a non-invasive biomarker. In the present study we evaluated the utility of circulating free DNA (cfDNA) and the sub-type tumor DNA (ctDNA) in hepatocellular cancer (HCC) patients to assess therapy respo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Med
Main Authors: Alunni-Fabbroni, Marianna, Rönsch, Kerstin, Huber, Thomas, Cyran, Clemens C., Seidensticker, Max, Mayerle, Julia, Pech, Maciej, Basu, Bristi, Verslype, Chris, Benckert, Julia, Malfertheiner, Peter, Ricke, Jens
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6771167/
https://ncbi.nlm.nih.gov/pubmed/31570105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-2079-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados